Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Rama Dronamraju

Psychiatry Boston, MA Medical Doctor

NPI 1790864098 CMS profile 414446

49 Robinwood Ave, Boston, MA 02130

Open in the dashboard

General payments

$2,196

102 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Rama Dronamraju of Boston, MA is reported in the CMS Open Payments database as having received $2,196 across 102 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 80th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $218 8
2024 General $254 10
2023 General $393 19
2022 General $314 14
2021 General $410 23
2020 General $403 21
2019 General $205 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rama Dronamraju
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Rama Dronamraju were reported at $218. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Rama Dronamraju Psychiatry median Middle half National median
2019 $205 $184 $59–$605 $163
2020 $403 $119 $36–$372 $114
2021 $410 $143 $43–$576 $132
2022 $314 $153 $50–$590 $149
2023 $393 $170 $56–$651 $160
2024 $254 $179 $57–$673 $164
2025 $218 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $450 23 payments
  2. Lundbeck LLC $369 18 payments
  3. Sunovion Pharmaceuticals Inc. $352 19 payments
  4. ITI, Inc. $261 11 payments
  5. Takeda Pharmaceuticals U.S.A., Inc. $202 9 payments
  6. Janssen Pharmaceuticals, Inc $154 3 payments
  7. Neurocrine Biosciences, Inc. $90 4 payments
  8. Vanda Pharmaceuticals Inc. $83 3 payments
  9. Bausch Health US, LLC $57 3 payments
  10. Otsuka America Pharmaceutical, Inc. $47 3 payments
  11. Other $133 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,149 101 payments
  2. Education $47 1 payment
Products named General payments · program years 2019–2025
  1. VRAYLAR Neuroscience $379 20 payments
  2. LATUDA $352 19 payments
  3. REXULTI $275 11 payments
  4. CAPLYTA $231 10 payments
  5. TRINTELLIX $162 7 payments
  6. SPRAVATO $154 3 payments
  7. BRINTELLIX $94 7 payments
  8. FANAPT $83 3 payments
  9. VRAYLAR Neuroscience $71 3 payments
  10. APLENZIN $57 3 payments
  11. Other $405 19 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

194

Median for Psychiatry: 574

Drug cost

$37,053

Median for Psychiatry: $27,624

Branded share of claims

22.7%

Median for Psychiatry: 17%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Spravato Esketamine Hcl Brand 16 $21,082
Trintellix Vortioxetine Hydrobromide Brand 16 $8,520
Aripiprazole Generic 21 $5,717
Fluoxetine Hcl Generic 12 $497
Divalproex Sodium Generic 19 $408
Duloxetine Hcl Generic 19 $319
Lamotrigine Generic 32 $311
Escitalopram Oxalate Generic 21 $104
Lorazepam Generic 26 $54
Bupropion Hcl Sr Bupropion Hcl Brand 12 $41

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 20,488 Part D prescribers listed as Psychiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 8 billing codes

Paid by Medicare

$17,162

Medicare's payments for the services billed

Medicare patients

15

Average age 65

Services billed

156

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Depression 75%
Heart failure 0%
COPD 0%
Cancer 0%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

5 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
REXULTI
  • Lundbeck LLC $124
$124 — —
TRINTELLIX
  • Takeda Pharmaceuticals U.S.A., Inc. $47
$47 16 —
VRAYLAR
  • AbbVie, Inc. $40
$40 — —
Secuado
  • Noven Therapeutics, LLC $25
$25 — —
Xelstrym
  • Noven Therapeutics, LLC $18
$18 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

102 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record